IDEAYA Biosciences, Inc.
Cash Flow History
| Period | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| Mar 2022 | $-19.6M | $-20.0M | $401.0K | $2.6M |
| Jun 2022 | $-20.0M | $-21.9M | $1.9M | $3.0M |
| Sep 2022 | $-24.2M | $-25.3M | $1.1M | $3.0M |
| Dec 2022 | $-23.4M | $-23.4M | $0 | $3.0M |
| Mar 2023 | $-27.8M | $-27.9M | $43.0K | $3.7M |
| Jun 2023 | $-33.5M | $-34.3M | $884.0K | $4.7M |
| Sep 2023 | $-30.2M | $-30.8M | $603.0K | $5.3M |
| Dec 2023 | $-23.7M | $-24.6M | $838.0K | $4.8M |
| Mar 2024 | $-43.8M | $-45.1M | $1.3M | $6.3M |
| Jun 2024 | $-32.9M | $-33.9M | $973.0K | $9.7M |
| Sep 2024 | $-49.2M | $-49.7M | $457.0K | $9.2M |
| Dec 2024 | $-121.7M | $-122.8M | $1.1M | $9.5M |
| Mar 2025 | $-60.3M | $-61.7M | $1.3M | $10.2M |
| Jun 2025 | $-62.5M | $-63.1M | $663.0K | $11.9M |
| Sep 2025 | $142.2M | $142.2M | $42.0K | $12.2M |
| Dec 2025 | $-90.5M | $-90.8M | $333.0K | $11.8M |
| Mar 2026 | $-75.2M | $-76.1M | $967.0K | $14.5M |
| Jun 2026 | $-88.2M | $-89.1M | $866.0K | $16.7M |